While they have never met, the women share the same experience of seeing their children battling addiction and having to ...
Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to sustain once treatment ends. Stopping treatment with weight loss medications is ...
Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...
The driver accelerated and eluded deputies, triggering a brief pursuit that ended when the vehicle crashed into an embankment ...
The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...
FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject ...
The American College of Cardiology found uneven gains and sobering declines in heart health. "You can't treat your way out of ...
Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...
Despite support from veterans, a push for more research and efforts to legalize the treatment, much remains unknown about ...
Fitgurú on MSN
The silent heart risk in your medicine cabinet: Why common pain relievers are under new medical scrutiny
Doctors issued a stark warning that routine over-the-counter painkillers could be driving a hidden crisis of hypertension and ...
Salmon and chicken are nutritious protein sources that can benefit your health, but they offer different amounts of fats, ...
New study demonstrates significant improvements in medication adherence and 6% lower odds of 30-day readmissions at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results